CGC - Why Canopy Growth At $18 Is A Great Investment Opportunity

• In this article, I explore two reasons why investors have a short-term bearish view against CGC.
• The two reasons are: 1) CGC shares will continue to dilute as they explore investment opportunities and 2) CGC will likely not meet their EBTIDA target for 2022.
• I think this short-term bearish sentiment provides an excellent opportunity for long-term investors, given the upcoming Marijuana reform bill by Schumer that’s set to be introduced after September 30th.
• Canopy Growth is one of the few cannabis companies that have the capacity to execute on CBD product nationwide immediately after regulatory framework is setup through its subsidiary BioSteel.
• Current price suggests a 12x terminal multiple, which is very low for a high growth company within an expanding industry.

For further details see: